© 2020 HealthDay. All rights reserved.
MONDAY, Sept. 14, 2020 -- A study to assess the effectiveness of two experimental COVID-19 vaccines when they are inhaled, rather than injected, has been announced by researchers.
The trial will test the responses of 30 people, ages 18 to 55 years, when they inhale vaccine droplets in their mouths, which would directly target their respiratory systems, explained the scientists at Imperial College London and Oxford University in the United Kingdom, the Associated Press reported.
"We have evidence that delivering influenza vaccines via a nasal spray can protect people against flu as well as help to reduce the transmission of the disease," and this might also be the case with the new coronavirus, research leader Chris Chiu, Ph.D., of Imperial College London, said in a statement.
Clinical trials of the vaccines' effectiveness when injected are already underway. "It is critical we explore whether targeting the airways directly can provide an effective response compared to a vaccine injected into muscle," according to Chiu, the AP reported.
© 2020 HealthDay. All rights reserved.
Posted: September 2020
MONDAY, Sept. 14, 2020 -- Among hospitalized patients without any severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated symptoms, children are less likely than adults...
MONDAY, Sept. 14, 2020 -- Oxford University has announced that final-stage testing of a COVID-19 vaccine it is developing with drug maker AstraZeneca will restart following a pause...
MONDAY, Sept. 14, 2020 -- For the first time in six months, Canada on Friday reported no new COVID-19 deaths. Reuters said the last time that happened was on March 15, at the start...